Pharmacy News Article

Pharmaceutical company Adamis Pharmaceuticals Corp (OTCBB:ADMP) declared on Wednesday the receipt of distribution contracts and initial stocking orders for prescription drugs in the US allergy market.

The agreements have been awarded to the company's wholly owned subsidiary, Adamis Labs, by three major wholesalers, which distribute approximately 90% of US drugs made by manufacturers.

Following the recent delivery of the product, Adamis' pre-filled epinephrine syringe (Epinephrine Injection USP 1:1000 [0.3mg]) will be available to most pharmacies in the US.

((Comments on this story may be sent to tww.feedback@m2.com))